0.2806
price down icon4.13%   -0.0121
after-market Dopo l'orario di chiusura: .28 -0.0006 -0.21%
loading
Precedente Chiudi:
$0.2927
Aprire:
$0.28
Volume 24 ore:
682.35K
Relative Volume:
1.83
Capitalizzazione di mercato:
$11.59M
Reddito:
$7.10M
Utile/perdita netta:
$-39.43M
Rapporto P/E:
-0.2985
EPS:
-0.94
Flusso di cassa netto:
$-46.50M
1 W Prestazione:
-4.91%
1M Prestazione:
-21.47%
6M Prestazione:
-38.45%
1 anno Prestazione:
-66.57%
Intervallo 1D:
Value
$0.27
$0.31
Intervallo di 1 settimana:
Value
$0.26
$0.31
Portata 52W:
Value
$0.26
$0.87

Spruce Biosciences Inc Stock (SPRB) Company Profile

Name
Nome
Spruce Biosciences Inc
Name
Telefono
(415) 655-4168
Name
Indirizzo
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Name
Dipendente
22
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
SPRB's Discussions on Twitter

Confronta SPRB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SPRB
Spruce Biosciences Inc
0.2806 11.59M 7.10M -39.43M -46.50M -0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-11 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2024-12-11 Downgrade Oppenheimer Outperform → Perform
2024-03-14 Downgrade Guggenheim Buy → Neutral
2024-03-14 Downgrade H.C. Wainwright Buy → Neutral
2024-03-14 Downgrade Ladenburg Thalmann Buy → Neutral
2024-03-14 Downgrade Leerink Partners Outperform → Market Perform
2024-03-14 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-21 Iniziato Guggenheim Buy
2021-12-17 Iniziato Oppenheimer Outperform
2021-12-10 Iniziato The Benchmark Company Speculative Buy
2021-11-16 Downgrade SVB Leerink Outperform → Mkt Perform
2021-07-19 Iniziato H.C. Wainwright Buy
2021-04-26 Ripresa Credit Suisse Outperform
2020-11-03 Iniziato Cowen Outperform
2020-11-03 Iniziato Credit Suisse Outperform
2020-11-03 Iniziato RBC Capital Mkts Outperform
2020-11-03 Iniziato SVB Leerink Outperform
Mostra tutto

Spruce Biosciences Inc Borsa (SPRB) Ultime notizie

pulisher
11:31 AM

Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace

11:31 AM
pulisher
Apr 01, 2025

Spruce Biosciences reports delayed annual filing By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Spruce Biosciences reports delayed annual filing - Investing.com

Apr 01, 2025
pulisher
Mar 31, 2025

Spruce Biosciences Delays Annual Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 31, 2025
pulisher
Mar 25, 2025

Spruce Biosciences stock hits 52-week low at $0.32 - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

In-Depth Analysis Of The Global Congenital Adrenal Hyperplasia Market: Key Drivers, Trends, Growth Opportun... - WhaTech

Mar 25, 2025
pulisher
Mar 22, 2025

SPRUCE BIOSCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 22, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 20, 2025
pulisher
Mar 14, 2025

Analysts Set Spruce Biosciences, Inc. (NASDAQ:SPRB) PT at $2.38 - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

SPRB Stock Touches 52-Week Low at $0.34 Amid Steep Decline - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 11, 2025
pulisher
Mar 05, 2025

Spruce Biosciences (SPRB) to Release Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Harbour Biomed newco HBM Alpha pens $395M hyperplasia drug deal - BioWorld Online

Mar 04, 2025
pulisher
Mar 04, 2025

SPRB stock touches 52-week low at $0.34 amid sharp annual decline - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Short Interest in Kingsoft Co. Limited (OTCMKTS:KSFTF) Increases By 79.4% - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Archer-Daniels-Midland Company (NYSE:ADM) Receives Consensus Rating of “Reduce” from Brokerages - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Traws Pharma, Inc. (NASDAQ:TRAW) Short Interest Update - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Short Interest Up 81.4% in February - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

SPRB stock touches 52-week low at $0.34 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Feb 28, 2025

Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 21, 2025

Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - MSN

Feb 21, 2025
pulisher
Feb 18, 2025

NeoGenomics (NEO) Tops Q4 Earnings Estimates - Yahoo Finance

Feb 18, 2025
pulisher
Feb 17, 2025

The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News

Feb 17, 2025
pulisher
Feb 17, 2025

Element Solutions Inc (NYSE:ESI) Receives $30.14 Consensus Price Target from Analysts - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

Alamos Gold Inc. (TSE:AGI) Receives C$28.78 Average Target Price from Brokerages - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Analysts - Defense World

Feb 17, 2025
pulisher
Feb 10, 2025

Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Spruce Biosciences Inc (NASDAQ: SPRB) Stock Has Gained 4.05% Over The Month – Is There Room For Growth? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Should You Expect Akero Therapeutics Inc (NASDAQ:AKRO) To Recover From Its 70.02% Gain From Highs? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Five Point Holdings LLC (NYSE: FPH): Can The Stock Still Lose Despite An 54.23% YTD Gain? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 07, 2025

Why you might not want to use AI to spruce up your job application - Yahoo

Feb 07, 2025
pulisher
Feb 04, 2025

Spruce Biosciences Inc (SPRB) Stock Price and Analyst Predictions - The News Heater

Feb 04, 2025
pulisher
Feb 04, 2025

Spruce Biosciences Inc (NASDAQ:SPRB) stock: You might be surprised - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Examining OppFi Inc (OPFI) stock is warranted - US Post News

Feb 04, 2025
pulisher
Jan 27, 2025

(PDF) Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials - ResearchGate

Jan 27, 2025
pulisher
Jan 23, 2025

Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $3.90 Consensus Target Price from Brokerages - Defense World

Jan 23, 2025

Spruce Biosciences Inc Azioni (SPRB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):